These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1124 related items for PubMed ID: 18625536

  • 21. Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.
    Levine DW, Dailey ME, Rockhill B, Tipping D, Naughton MJ, Shumaker SA.
    Psychosom Med; 2005; 67(1):98-104. PubMed ID: 15673630
    [Abstract] [Full Text] [Related]

  • 22. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K.
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [Abstract] [Full Text] [Related]

  • 23. Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
    Samsioe G, Hruska J, CHOICE Study Investigators.
    Climacteric; 2010 Feb; 13(1):34-44. PubMed ID: 20001563
    [Abstract] [Full Text] [Related]

  • 24. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK, Hinderliter AL.
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK, Bunyavejchevin S.
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [Abstract] [Full Text] [Related]

  • 27. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
    Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS.
    Menopause; 2006 Apr; 13(5):780-6. PubMed ID: 16894334
    [Abstract] [Full Text] [Related]

  • 28. Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators.
    Symons J, Kempfert N, Speroff L.
    Obstet Gynecol; 2000 Sep; 96(3):366-72. PubMed ID: 10960627
    [Abstract] [Full Text] [Related]

  • 29. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Sep; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 30. Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens.
    Simon JA, Symons JP, femhrt Study Investigators.
    Menopause; 2001 Sep; 8(5):321-7. PubMed ID: 11528357
    [Abstract] [Full Text] [Related]

  • 31. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L.
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [Abstract] [Full Text] [Related]

  • 32. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
    Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP.
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
    [Abstract] [Full Text] [Related]

  • 33. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
    Adler G, Young D, Galant R, Quinn L, Witchger MS, Maki KC.
    Gynecol Obstet Invest; 2005 Jan; 59(4):212-9. PubMed ID: 15753617
    [Abstract] [Full Text] [Related]

  • 34. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome.
    Simon JA, Stevens RE, Ayres SA, Phelps KV.
    Climacteric; 2001 Mar; 4(1):19-27. PubMed ID: 11379374
    [Abstract] [Full Text] [Related]

  • 35. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
    Lundström E, Bygdeson M, Svane G, Azavedo E, von Schoultz B.
    Climacteric; 2007 Jun; 10(3):249-56. PubMed ID: 17487652
    [Abstract] [Full Text] [Related]

  • 36. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB, Koontz SL, Nichols MD, Jensen JT.
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [Abstract] [Full Text] [Related]

  • 37. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J, Smetnik VP, Vadász P, Mustonen M, Salminen K, Ylikangas S, Indivina 321 Study Group.
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [Abstract] [Full Text] [Related]

  • 38. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF, Andrade AT, Ribeiro LC, Castro IQ, Brandão M, Polisseni F, Guerra Mde O.
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [Abstract] [Full Text] [Related]

  • 39. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS, Rose PA, Kim HM, Kehrer C, Brook RD.
    J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA, Skouby S, Rees M, Heikkinen J, Kudela M, Stadnicki-Kolendo A, Mattila L, Salminen K, Vuorela A, Mustonen M, Indivina 321 Study Group.
    Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.